Hematology, Transfusion and Cell Therapy (Nov 2020)

COVID-19 IN A PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN USE OF IBRUTINIB: NOT THAT RISKY?

M.L.B.F. Dourado,
V.B.A.S. Eira,
G. Matias,
O.C.C.G. Baiocchi

Affiliations

M.L.B.F. Dourado: Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil
V.B.A.S. Eira: Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil
G. Matias: Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil
O.C.C.G. Baiocchi: Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil

Journal volume & issue: Vol. 42
p. 526

Abstract

No abstracts available.

Published in Hematology, Transfusion and Cell Therapy

ISSN: 2531-1379 (Print); 2531-1387 (Online)
Publisher: Elsevier
Country of publisher: Spain
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
Website: https://www.journals.elsevier.com/hematology-transfusion-and-cell-therapy

About the journal